Abstract:Apolipoprotein B mRNA editing enzyme catalytic subunit 3 (APOBEC3) proteins are critical for the control of infection by retroviruses. These proteins deaminate cytidines in negative-strand DNA during reverse transcription, leading to G-to-A changes in coding strands. Uracil DNA glycosylase (UNG) is a host enzyme that excises uracils in genomic DNA, which the base excision repair machinery then repairs. Whether UNG removes uracils found in retroviral DNA after APOBEC3-mediated mutation is not clear, and whether this occurs in vivo has not been demonstrated. To determine if UNG plays a role in the repair of retroviral DNA, we used APOBEC3G (A3G) transgenic mice which we showed previously had extensive deamination of murine leukemia virus (MLV) proviruses. The A3G transgene was crossed onto an Ung and mouse Apobec3 knockout background (UNG-/-APO-/-), and the mice were infected with MLV. We found that virus infection levels were decreased in A3G UNG-/-APO-/- compared with A3G APO-/- mice. Deep sequencing of the proviruses showed that there were significantly higher levels of G-to-A mutations in proviral DNA from A3G transgenic UNG-/-APO-/- than A3G transgenic APO-/- mice, suggesting that UNG plays a role in the repair of uracil-containing proviruses. In in vitro studies, we found that cytoplasmic viral DNA deaminated by APOBEC3G was uracilated. In the absence of UNG, the uracil-containing proviruses integrated at higher levels into the genome than those made in the presence of UNG. Thus, UNG also functions in the nucleus prior to integration by nicking uracil-containing viral DNA, thereby blocking integration. These data show that UNG plays a critical role in the repair of the damage inflicted by APOBEC3 deamination of reverse-transcribed DNA. IMPORTANCE While APOBEC3-mediated mutation of retroviruses is well-established, what role the host base excision repair enzymes play in correcting these mutations is not clear. This question is especially difficult to address in vivo. Here, we use a transgenic mouse developed by our lab that expresses human APOBEC3G and also lacks the endogenous uracil DNA glycosylase (Ung) gene and show that UNG removes uracils introduced by this cytidine deaminase in MLV reverse transcripts, thereby reducing G-to-A mutations in proviruses. Furthermore, our data suggest that UNG removes uracils at two stages in infection-first, in unintegrated nuclear viral reverse-transcribed DNA, resulting in its degradation; and second, in integrated proviruses, resulting in their repair. These data suggest that retroviruses damaged by host cytidine deaminases take advantage of the host DNA repair system to overcome this damage.

APOBEC3G rescues cells from the deleterious effects of DNA damage

APOBEC3C, a nucleolar protein induced by genotoxins, is excluded from DNA damage sites

APOBEC3A can activate the DNA damage response and cause cell‐cycle arrest

USP49 Potently Stabilizes APOBEC3G Protein by Removing Ubiquitin and Inhibits HIV-1 Replication

APOBEC3B reporter myeloma cell lines identify DNA damage response pathways leading to APOBEC3B expression

The DNA damage induced by the Cytosine Deaminase APOBEC3A Leads to the production of ROS

Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer

APOBEC3A damages the cellular genome during DNA replication

Involvement of APOBEC3B in mutation induction by irradiation

Repair of APOBEC3G-Mutated Retroviral DNA In Vivo Is Facilitated by the Host Enzyme Uracil DNA Glycosylase 2

The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities

Protein interaction map of APOBEC3 enzyme family reveals deamination-independent role in cellular function

Regulation, functional impact, and therapeutic targeting of APOBEC3A in cancer

AID, APOBEC3A and APOBEC3B efficiently deaminate deoxycytidines neighboring DNA damage induced by oxidation or alkylation

Small‐Molecule APOBEC3G DNA Cytosine Deaminase Inhibitors Based on a 4‐amino‐1,2,4‐triazole‐3‐thiol Scaffold

Multiple ubiquitin ligases protect human genome integrity by targeting cancer-associated APOBEC3 deaminases for degradation

Dnar-16. Targeting Apobec Cytidine Deaminases To Enhance Radiosensitivity In Glioma

The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead

Mechanisms of APOBEC3 mutagenesis in human cancer cells

Interaction with the CCT chaperonin complex limits APOBEC3A cytidine deaminase cytotoxicity

APOBEC3 proteins and genomic stability